Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Preferred Stock Liabilities: 2015-2024

Historic Preferred Stock Liabilities for Wave Life Sciences (WVE) over the last 10 years, with Dec 2024 value amounting to $7.9 million.

  • Wave Life Sciences' Preferred Stock Liabilities changed negligibly% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $7.9 million for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from FY2024, Wave Life Sciences' Preferred Stock Liabilities is $7.9 million, which was down 0.00% from $7.9 million recorded in FY2023.
  • Wave Life Sciences' Preferred Stock Liabilities' 5-year high stood at $7.9 million during FY2020, with a 5-year trough of $7.9 million in FY2020.
  • For the 3-year period, Wave Life Sciences' Preferred Stock Liabilities averaged around $7.9 million, with its median value being $7.9 million (2024).